These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2847658)

  • 1. Human placental fibronectin: demonstration of structural differences between the A and B chains in the extra domain-A region.
    Tressel T; Shively JE; Pande H
    Arch Biochem Biophys; 1988 Nov; 266(2):639-43. PubMed ID: 2847658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human plasma fibronectin. Demonstration of structural differences between the A- and B-chains in the III CS region.
    Tressel T; McCarthy JB; Calaycay J; Lee TD; Legesse K; Shively JE; Pande H
    Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):731-8. PubMed ID: 2012601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain.
    Pande H; Calaycay J; Lee TD; Legesse K; Shively JE; Siri A; Borsi L; Zardi L
    Eur J Biochem; 1987 Jan; 162(2):403-11. PubMed ID: 3803394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin.
    Zhu BC; Fisher SF; Pande H; Calaycay J; Shively JE; Laine RA
    J Biol Chem; 1984 Mar; 259(6):3962-70. PubMed ID: 6423638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin.
    Calaycay J; Pande H; Lee T; Borsi L; Siri A; Shively JE; Zardi L
    J Biol Chem; 1985 Oct; 260(22):12136-41. PubMed ID: 3900070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of porcine plasma fibronectin and its fragmentation by porcine liver cathepsin B.
    Isemura M; Yosizawa Z; Takahashi K; Kosaka H; Kojima N; Ono T
    J Biochem; 1981 Jul; 90(1):1-9. PubMed ID: 6457032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneity.
    Garcia-Pardo A; Rostagno A; Frangione B
    Biochem J; 1987 Feb; 241(3):923-8. PubMed ID: 3593230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elution of fibronectin proteolytic fragments from a hydroxyapatite chromatography column. A simple procedure for the purification of fibronectin domains.
    Zardi L; Carnemolla B; Balza E; Borsi L; Castellani P; Rocco M; Siri A
    Eur J Biochem; 1985 Feb; 146(3):571-9. PubMed ID: 2982601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of human placenta fibronectin.
    Isemura M; Yamaguchi Y; Munakata H; Aikawa J; Kan M; Yamane I; Yosizawa Z
    J Biochem; 1984 Jul; 96(1):163-9. PubMed ID: 6436230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of two binding domains for thrombospondin within fibronectin.
    Zafar RS; Zeng Z; Walz DA
    Arch Biochem Biophys; 1992 Sep; 297(2):271-6. PubMed ID: 1497347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.
    McCarthy JB; Skubitz AP; Qi Z; Yi XY; Mickelson DJ; Klein DJ; Furcht LT
    J Cell Biol; 1990 Mar; 110(3):777-87. PubMed ID: 2307707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary structure of human plasma fibronectin. The 29,000-dalton NH2-terminal domain.
    Garcia-Pardo A; Pearlstein E; Frangione B
    J Biol Chem; 1983 Oct; 258(20):12670-4. PubMed ID: 6630202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary structure of human plasma fibronectin. Characterization of a 31,000-dalton fragment from the COOH-terminal region containing a free sulfhydryl group and a fibrin-binding site.
    Garcia-Pardo A; Pearlstein E; Frangione B
    J Biol Chem; 1985 Aug; 260(18):10320-5. PubMed ID: 4019516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model of fibronectin tertiary structure based on studies of interactions between fragments.
    Homandberg GA; Erickson JW
    Biochemistry; 1986 Nov; 25(22):6917-25. PubMed ID: 3801402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of heparin-binding sites of fibronectin. Detection of a hitherto unrecognized transamidase sensitive site.
    Richter H; Seidl M; Hörmann H
    Hoppe Seylers Z Physiol Chem; 1981 Apr; 362(4):399-408. PubMed ID: 7239439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late cathepsin D-derived fragments of fibronectin containing the C-terminal interchain disulfide cross-link.
    Richter H; Hörmann H
    Hoppe Seylers Z Physiol Chem; 1982 Apr; 363(4):351-64. PubMed ID: 7076131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polylactosamine glycosylation on human fetal placental fibronectin weakens the binding affinity of fibronectin to gelatin.
    Zhu BC; Laine RA
    J Biol Chem; 1985 Apr; 260(7):4041-5. PubMed ID: 3920213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities.
    McCarthy JB; Chelberg MK; Mickelson DJ; Furcht LT
    Biochemistry; 1988 Feb; 27(4):1380-8. PubMed ID: 2966638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin.
    Lambert Vidmar S; Lottspeich F; Emod I; Planchenault T; Keil-Dlouha V
    Eur J Biochem; 1991 Oct; 201(1):71-7. PubMed ID: 1915379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.